Aggressive treatment may not kill resistant pathogens

Image
IANS Washington
Last Updated : Oct 04 2014 | 11:55 AM IST

A study has questioned the accepted wisdom that aggressive treatment with high-drug dosages over long duration is the best way to stem the emergence and spread of resistant pathogens.

The logic behind aggressive treatment is to kill off as many microbes as you can, so that few will be around to evolve into resistant forms.

However, the new study reveals the lack of evidence behind the practice of aggressive treatment in many cases.

Microbes like bacteria and parasites can evade powerful drugs by undergoing genetic mutations, which enable them to avoid being killed by the drug, said the researchers.

"We found that while there are many studies that test for resistance emergence between different drug regimes, surprisingly few have looked at the topic of how varying drug dosage might affect the emergence and spread of resistance," said Ruthie Birger, from the Princeton University in the US, who works with C. Jessica Metcalf, an assistant professor of ecology and evolutionary biology at Princeton's Woodrow Wilson school.

"We are a long way from having the evidence for the best treatment decisions with respect to resistance for a range of diseases," Birger said.

From a study on a mice, scientists found that the high-dose drug treatment killed off the non-resistant malarial parasites, leaving the resistant strains to multiply and make the mice even sicker.

Taking a cue from the experiment on mice, the authors of the current study examined whether the same may be true for other types of microbes such as bacteria.

Finding the ideal dose and duration of treatment, one that cures the patient without aiding the spread of resistance, will likely be done on a disease by disease basis, the authors found.

Aggressive treatment might be best for pathogens that develop resistance slowly, over the course of several mutations. High-doses early in the process could be effective at heading off the development of resistance, concluded the researchers.

The study was published in the journal Proceedings of the Royal Society B

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 04 2014 | 11:52 AM IST

Next Story